C
0.295
-0.02 (-7.52%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Co-Diagnostics, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 价值 35% | 0.0 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | 0.0 |
| 时机 35% | -0.5 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -2.5 |
| 技术平均移动指标 参考 | 2.5 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 市场环境 | ×1.17 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -6.8% |
| 支柱一致性 | ×1.00 |
| 不计入评分 | |
| 价格波动 参考 | 0.5 |
| 最终评分 | -0.20 |
|
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 9.00% |
| 机构持股比例 | 17.44% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Private Advisory Group Llc | 30 Sep 2026 | 39,387 |
该时间范围内无数据。
该时间范围内无数据。
投资组合